T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Match Group
MTCH
|
+$3.17B |
| 2 |
Nike
NKE
|
+$1.94B |
| 3 |
Bank of America
BAC
|
+$1.84B |
| 4 |
FedEx
FDX
|
+$1.78B |
| 5 |
PNC Financial Services
PNC
|
+$1.61B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$4.1B |
| 2 |
Fortive
FTV
|
+$2.54B |
| 3 |
Linde
LIN
|
+$1.53B |
| 4 |
Alibaba
BABA
|
+$1.35B |
| 5 |
Willis Towers Watson
WTW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.99% |
| 2 | Healthcare | 16.87% |
| 3 | Consumer Discretionary | 15.81% |
| 4 | Financials | 11.47% |
| 5 | Communication Services | 10.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.69B
| $10.8M | ﹤0.01% |
+256,880
| New | +$12.9M |
|
|
FLIR
1277
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $10.8M | ﹤0.01% |
301,034
-15,664
| -5% | -$597K |
|
1278
Sixth Street Specialty
TSLX
$1.79B
| $10.8M | ﹤0.01% |
625,000
| – | – |
|
|
ELAT
1279
DELISTED
Elanco Animal Health Incorporated 5.00% Tangible Equity Units
ELAT
| $10.7M | ﹤0.01% |
241,674
-55,095
| -19% | -$2.33M |
|
|
RAVN
1280
DELISTED
Raven Industries Inc
RAVN
| $10.7M | ﹤0.01% |
495,534
| – | – |
|
1281
Genpact
G
$5.78B
| $10.7M | ﹤0.01% |
273,702
-3,802
| -1% | -$150K |
|
|
EIDX
1282
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $10.7M | ﹤0.01% |
210,757
-25,393
| -11% | -$1.14M |
|
1283
Essential Utilities
WTRG
$11.3B
| $10.6M | ﹤0.01% |
262,852
-48,326
| -16% | -$2.08M |
|
1284
Hubbell
HUBB
$26.8B
| $10.5M | ﹤0.01% |
76,870
-84,786
| -52% | -$11.7M |
|
1285
STRATTEC Security
STRT
$338M
| $10.5M | ﹤0.01% |
526,981
| – | – |
|
|
LDL
1286
DELISTED
Lydall, Inc.
LDL
| $10.3M | ﹤0.01% |
625,696
+1,700
| +0.3% | +$29.6K |
|
1287
Leggett & Platt
LEG
$1.29B
| $10.3M | ﹤0.01% |
251,298
-9,362
| -4% | -$372K |
|
1288
Phibro Animal Health
PAHC
$1.38B
| $10.2M | ﹤0.01% |
587,801
+3,957
| +0.7% | +$84.4K |
|
1289
Chegg
CHGG
$89.3M
| $10.2M | ﹤0.01% |
143,018
+962
| +0.7% | +$70.8K |
|
1290
Dynatrace
DT
$14.7B
| $10.2M | ﹤0.01% |
247,881
-1,592
| -0.6% | -$65.2K |
|
1291
Assembly Biosciences
ASMB
$536M
| $10.2M | ﹤0.01% |
51,520
-5,241
| -9% | -$1.32M |
|
1292
Lincoln National
LNC
$8.67B
| $10.1M | ﹤0.01% |
323,339
-53,938
| -14% | -$1.93M |
|
1293
Vornado Realty Trust
VNO
$7.33B
| $10.1M | ﹤0.01% |
299,236
-290,567
| -49% | -$10.4M |
|
1294
Teck Resources
TECK
$31.3B
| $9.95M | ﹤0.01% |
714,513
+107,610
| +18% | +$1.27M |
|
1295
Dyne Therapeutics
DYN
$4.85B
| $9.92M | ﹤0.01% |
+491,471
| New | +$10.8M |
|
|
AIV
1296
Aimco
AIV
$379M
| $9.89M | ﹤0.01% |
2,201,716
-78,228
| -3% | -$379K |
|
1297
Replimune Group
REPL
$1.42B
| $9.81M | ﹤0.01% |
426,161
+38,822
| +10% | +$885K |
|
1298
Ichor Holdings
ICHR
$2.67B
| $9.77M | ﹤0.01% |
453,047
+6,042
| +1% | +$161K |
|
1299
Vistra
VST
$49.1B
| $9.76M | ﹤0.01% |
517,554
-19,299
| -4% | -$364K |
|
1300
iHeartMedia
IHRT
$450M
| $9.71M | ﹤0.01% |
1,196,363
+6,967
| +0.6% | +$59.3K |
|
Similar funds
T. Rowe Price Associates's Q3 2020 Portfolio in Review
As of Q3 2020, T. Rowe Price Associates held 2,679 positions worth $864B, up 8.7% from $795B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2020 filing shows 185 new, 873 increased, 1,330 reduced and 90 closed positions. Its largest new stake was nCino: 5,133,240 shares worth $395M. The largest sale was People Inc, an estimated $4.1B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2020 buy was nCino: 5,133,240 shares worth $395M.
- T. Rowe Price Associates added most to Match Group in Q3 2020, an estimated $3.17B increase.
- T. Rowe Price Associates's biggest Q3 2020 reduction was People Inc, cutting an estimated $4.1B.
- T. Rowe Price Associates fully exited 58.com Inc in Q3 2020, selling an estimated $468M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $864B portfolio in Q3 2020.
- T. Rowe Price Associates opened 185 new positions and closed 90 in Q3 2020.
- T. Rowe Price Associates's portfolio value rose 8.7% quarter-over-quarter to $864B.
Based on T. Rowe Price Associates's 13F filing for Q3 2020, filed 16 Nov 2020.